Atıf Formatları
Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. Salman Et Al. , "Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data," AUSTRALASIAN JOURNAL OF DERMATOLOGY , vol.62, no.3, pp.398-402, 2021

Salman, A. Et Al. 2021. Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data. AUSTRALASIAN JOURNAL OF DERMATOLOGY , vol.62, no.3 , 398-402.

Salman, A., Aktas, M., & Sengun, O. A., (2021). Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data. AUSTRALASIAN JOURNAL OF DERMATOLOGY , vol.62, no.3, 398-402.

Salman, ANDAÇ, Meryem Aktas, And Ozlem Apti Sengun. "Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data," AUSTRALASIAN JOURNAL OF DERMATOLOGY , vol.62, no.3, 398-402, 2021

Salman, ANDAÇ Et Al. "Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data." AUSTRALASIAN JOURNAL OF DERMATOLOGY , vol.62, no.3, pp.398-402, 2021

Salman, A. Aktas, M. And Sengun, O. A. (2021) . "Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data." AUSTRALASIAN JOURNAL OF DERMATOLOGY , vol.62, no.3, pp.398-402.

@article{article, author={ANDAÇ SALMAN Et Al. }, title={Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data}, journal={AUSTRALASIAN JOURNAL OF DERMATOLOGY}, year=2021, pages={398-402} }